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Case Report

Troponin leak associated with drug-induced methemoglobinemia☆,☆☆,★

Abstract
Drug-induced methemoglobinemia is a well-described entity
but has not been previously associated with elevated troponins
in the absence of cardiac symptoms. We report a case of a patient
presenting to the emergency department (ED) with complaints
related to an exacerbation of her long-standing cystitis. A low
pulse oximetry reading prompted an evaluation, revealing a
troponin leak, which peaked at 10 hours. Her methemoglobin
level was found to be elevated at 11.4%, but a preexisting anemia
apparently prevented the clinical recognition of cyanosis. The
methemoglobinemia was determined to be secondary to her
ingestion of phenazopyridine and trimethoprim-sulfamethoxizole.
Although phenazopyridine and sulfa agents have long been known
to cause methemoglobinemia, our patient exhibited an asymptomatic
troponin leak that has not been previously reported as a complication
of drug-induced methemoglobinemia. Clinicians should be aware of this
potential association.
A 59-year-old white woman presented to the emergency
department (ED) with a chief complaint of abdominal pain for 36
hours. Medical history was positive for chronic cystitis for several
years of duration, hypertension, hyperlipidemia, bipolar disorder,
and low back pain. She was a nonsmoker with a remote 10-pack-year
history. She had been taking phenazopyridine 100 mg 4 times a day
for approximately 2 months and had taken one dose of trimethoprim-sulfamethoxizole the evening before her ED visit for presumed
urinary tract infection. Other medicines included lamotrigine,
amitriptyline, venlafaxine XR, olanzapine, aspirin, diltiazem, simvastatin, hydrochlorothiazide, zolpidem, fentanyl patch, hydrocodone/
acetaminophen as needed (prn), and acetaminophen/codeine (prn).
Her abdominal pain was mostly suprapubic; she had no complaints of
chest pain, shortness of breath, or cyanosis.
Vital signs included oxygen saturation, 91% on room air; pulse,
97 mm Hg; blood pressure, 167/99 mm Hg; and respiratory rate, 18
breaths/min. She was afebrile. Three liters of oxygen by nasal
cannula only increased her oxygen saturation to 92%. Physical
examination was notable only for suprapubic and unilateral ﬂank
tenderness. There were no cardiac or pulmonary ﬁndings; there
was no cyanosis. Electrocardiogram demonstrated a left bundle
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branch block, which was unchanged from prior testing. Computed
tomography of the abdomen and chest were normal. Notable
laboratory abnormalities were hemoglobin level of 9.3 g/dL (similar
to prior values).
An arterial blood gas (ABG) on 3 L by nasal cannula revealed pH, 7.36;
carbon dioxide, 41 mm Hg; oxygen, 114 mm Hg; serum bicarbonate, 22.2
meq/L; oxygen saturation, 97%; and oxygen content, 10.6 mL/dL (normal
15-33 mL/dL). Cooximetry revealed a methemoglobin level of 11.4%,
(normal b 3), oxyhemoglobin of 82.5%, and carboxyhemoglobin of 3.7%.
The patient’s serial troponin I levels were as follows: (1) b 0.04 ng/mL
at 14:56, (2) 0.20 ng/mL at 18:41, (3) 0.41 ng/mL at 01:20, and
(4) 0.33 ng/mL at 04:15. A cardiology consult was obtained, and the
patient was admitted to a monitored bed. Methylene blue was not
given as the patient was asymptomatic, and there were no new
ischemic changes on her ECG. On discharge 2 days later, she had no
evidence of cardiac ischemia; phenazopyridine and trimethoprimsulfamethoxizole were discontinued.
Acquired methemoglobinemia occurs when the oxygen carrying
ferrous iron (Fe 2 +) in the hemoglobin molecule is oxidized to the
ferric state (Fe 3 +) as a result of exposure to oxidizing drugs or their
metabolites. Methemoglobin causes tissue hypoxia by 2 mechanisms: increased afﬁnity for oxygen, which shifts the oxygen
dissociation curve to the left and decreasing the amount of free
hemoglobin available to transport oxygen [1]. Phenazopyridine has long
been known to cause methemoglobinemia as a result of its major
metabolite, aniline.
Methemoglobinemia after phenazopyridine ingestion has been
reported after both overdose and usual dosing and in the
absence of renal dysfunction [2-5]. Trimethoprim-sulfamethoxasole has also been reported to cause methemoglobinemia [1].
Saha et al [6] report acute methemoglobinemia causing
cardiorespiratory failure after topical benzocaine that responded
to methylene blue therapy. To our knowledge, elevated troponin
I secondary to methemoglobinemia has not been previously
reported [7].
Methemoglobin commonly results in cyanosis because of its
pigmentation; only 1.5 g/dL of methemoglobin is necessary to cause
visible cyanosis. In contrast, approximately 5 g/dL of deoxyhemoglobin
is necessary before cyanosis results. Our patient was anemic at baseline
(hemoglobin level 9.3 g/dL). With 11.4% methemoglobin, our patient’s
absolute concentration of methemoglobin was roughly 1.0 g/dL and
insufﬁcient to cause the clinical ﬁnding of cyanosis. Having 1.0 g/dL
of methemoglobin left only 8.3 g/dL of normal hemoglobin level to
carry and deliver oxygen to the tissues. Although the methemoglobin percentage was relatively low, anemia caused increased
susceptibility to even small derangements in oxygen carrying
capacity and delivery.
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Pulse oximeters measure absorbance at the peak wavelengths
of oxyhemoglobin and deoxyhemoglobin (940 nm and 660 nm,
respectively). They compare the ratio of oxyhemoglobin to
deoxyhemoglobin to determine the percentage of total oxygensaturated hemoglobin level. Because methemoglobin’s absorption
at these wavelengths is greater than that of either oxyhemoglobin
or deoxyhemoglobin, pulse oximeter readings become inaccurate.
These readings tend to decrease as methemoglobin levels
increase but not necessarily in a proportional manner [8].
If an abnormal species of hemoglobin is present, like methemoglobin, the calculated oxygen saturation on ABG will be
falsely elevated. This difference between the oxygen saturation
from the pulse oximeter and the blood level is known as
the “saturation gap.” It can be a clue to the presence of an
abnormal hemoglobin species, prompting further evaluation.
Our patient exhibited this phenomenon—her oxygen saturation
persistently read 88% to 91%, yet on ABG it was resulted
at 97%. Cooximetry must be used when a suspected
abnormal hemoglobin species is present. A cooximeter can
identify accurate proportions of multiple hemoglobin species at
different wavelengths.
We hypothesize that, in this patient with baseline anemia
(9.3 mg/dL), induction of methemoglobinemia (11%) caused
sufﬁcient tissue hypoxia to cause stress ischemia, even in
the absence of coronary artery disease. It is likely that the
addition of sulfa drug hours before presentation exacerbated
the methemoglobinemia.
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